Position in INDV
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$2,895,600
New position
Shares Held
95,000
first reported quarter
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swedbank AB holds $732,986,628 across 6 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,004,200 | $355,126,482 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
327,122 | $193,976,803 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,228,743 | $93,200,156 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
579,429 | $76,333,976 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
380,266 | $11,453,611 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
95,000 | $2,895,600 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,895,600 | 95,000 | Shares | Defined | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||